SLRN

ACELYRIN
SLRN

Overview Fund Activity
Delisted

SLRN was delisted on the 21st of May, 2025.

Back to rankings

125 hedge funds and large institutions have $276M invested in ACELYRIN in 2024 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 44 increasing their positions, 40 reducing their positions, and 14 closing their positions.

Holders
125
Holders Change
+3
Holders Change %
+2.46%
% of All Funds
1.66%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
18
Increased
44
Reduced
40
Closed
14
Calls
$22K
Puts
$4K
Net Calls
+$18K
Net Calls Change
+$136K

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$40.4M
2
Alyeska Investment Group
2
Alyeska Investment Group
Illinois
$4.76M
3
Morgan Stanley
3
Morgan Stanley
New York
$7.3M
4
ACM
4
ADAR1 Capital Management
Texas
$1.4M
5
SC
5
Stempoint Capital
New York
$5.35M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$13.2M
2
Millennium Management
2
Millennium Management
New York
$14.8M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$2.08M
4
ACP
4
Acuta Capital Partners
California
$0
5
WP
5
Woodline Partners
California
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$40.4M +$7.66M +2,440,278 +23%
ACMC
2
AyurMaya Capital Management Company
New Hampshire
$29.3M – – –
BlackRock
3
BlackRock
New York
$18.9M +$121K +38,494 +0.6%
Millennium Management
4
Millennium Management
New York
$14.8M -$2.43M -772,770 -14%
Citadel Advisors
5
Citadel Advisors
Florida
$13.2M -$7.26M -2,311,390 -35%
Vanguard Group
6
Vanguard Group
Pennsylvania
$12.8M +$40.9K +13,021 +0.3%
O
7
OrbiMed
New York
$12.6M – – –
VP
8
venBio Partners
California
$12M -$145K -46,060 -1%
TCM
9
Tybourne Capital Management
Hong Kong
$9.13M – – –
BOCH
10
Blue Owl Capital Holdings
New York
$8.74M -$31.4K -10,000 -0.4%
GA
11
General Atlantic
New York
$8.46M -$610K -194,341 -7%
SB
12
Samsara BioCapital
California
$7.92M – – –
Morgan Stanley
13
Morgan Stanley
New York
$7.3M +$1.69M +537,068 +30%
OM
14
Opaleye Management
Massachusetts
$7.17M +$1.1M +341,340 +18%
PAI
15
Palo Alto Investors
California
$5.63M – – –
SL
16
Siren LLC
Connecticut
$5.43M – – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$5.37M +$181K +57,472 +3%
SC
18
Stempoint Capital
New York
$5.35M +$1.22M +386,971 +29%
Alyeska Investment Group
19
Alyeska Investment Group
Illinois
$4.76M +$4.76M +1,515,878 New
State Street
20
State Street
Massachusetts
$4.53M +$528K +168,177 +13%
RI
21
RTW Investments
New York
$3.07M – – –
KCM
22
Kynam Capital Management
New Jersey
$2.66M – – –
IC
23
Ikarian Capital
Texas
$2.12M -$1.46K -466 -0.1%
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$2.08M -$2.08M -663,410 -50%
Northern Trust
25
Northern Trust
Illinois
$1.98M +$72.6K +23,130 +4%
1
2 3 4 5